Hedskog, C.; Spinner, C.D.; Protzer, U.; Hoffmann, D.; Ko, C.; Gottlieb, R.L.; Askar, M.; Roestenberg, M.; de Vries, J.J.C.; Carbo, E.C.;
et al. No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses 2024, 16, 546.
https://doi.org/10.3390/v16040546
AMA Style
Hedskog C, Spinner CD, Protzer U, Hoffmann D, Ko C, Gottlieb RL, Askar M, Roestenberg M, de Vries JJC, Carbo EC,
et al. No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses. 2024; 16(4):546.
https://doi.org/10.3390/v16040546
Chicago/Turabian Style
Hedskog, Charlotte, Christoph D. Spinner, Ulrike Protzer, Dieter Hoffmann, Chunkyu Ko, Robert L. Gottlieb, Medhat Askar, Meta Roestenberg, Jutte J. C. de Vries, Ellen C. Carbo,
and et al. 2024. "No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials" Viruses 16, no. 4: 546.
https://doi.org/10.3390/v16040546
APA Style
Hedskog, C., Spinner, C. D., Protzer, U., Hoffmann, D., Ko, C., Gottlieb, R. L., Askar, M., Roestenberg, M., de Vries, J. J. C., Carbo, E. C., Martin, R., Li, J., Han, D., Rodriguez, L., Parvangada, A., Perry, J. K., Ferrer, R., Antón, A., Andrés, C.,
... Porter, D. P.
(2024). No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials. Viruses, 16(4), 546.
https://doi.org/10.3390/v16040546
